Dr. Harsinen Subject
Dr. Harsinen Subject
Dr. Harsinen Subject
Harsinen Sanusi
ACTH
GH
PITUITARY ADENOMA
Pituitary tumors
Pituitary tumors are the most common diseases of the pituitary gland Benign and monoclonal - arise from single type of anterior pituitary cells
Variable presentation
Pituitary tumors
Hypersecretion
Function
Insufficiency
Microadenoma
Size
Macroadenoma
Non invasive
Invasive
Excessive pituitary GH-Secretion Normal pituitary GH-Secretion
Pituitary Adenomas
Commonnest causes Majority are hypersecreting
Endocrinologic abnormality
Pituitary Hypersecretion
PRL most commonly secreted by adenoma hyperprolactinemia GH Acromegaly ACTH Cushings disease
ACROMEGALY
Etiology: excessive pituitary GH secretion Sex incidence equal Mean age at diagnosis is approximately 40 years Duration of symptoms usually 5-10 years before the diagnosis established Increased late morbidity and mortality if untreated slowly progressive and spontaneous remission
Adults : linear growth does not occur, because of prior fusion of the epiphyses of long bones. Childhood & adoloscence Gigantism
Clinical manifestations of
acromegaly
Disturbance of other endocrine function: hyperinsulinemia, glucose intolerance, irregular or absent menses, decreased libido, hypothyroidism, galactorrhea, gynaecomastia, hyperadrenalism
Local manifestations
Enlarged sella Head ache Visual deficit
Laboratory finding
GH hypersecretion > 10 ng /mL
postprandial hyperglycemia, serum insulin is increased, elevated serum phosphorus, hypercalciuria
Imaging study
Plain films: Sellar enlargement (90% cases), Enlargement of the frontal, maxillary sinuses and the jaw Thickening of the calvarium Increased thickness of the heel pad MRI
Diagnostics
Laboratory findings: GH increase 10 ng/mL (N= 1-5 ng/mL), pp plasma glucose, serum insulin, serum phosphor , hypercalciuria Imaging studies: Plain film 90% casessellar enlargement Enlargement of jaw, maxillary sinuses, increased soft tissue bulk
Treatment
Removal or destruction of pituitary tumor Reversal of GH hypersecretion Maintenance of normal pituitary function Criteria for adequate respons GH< 5 ng/mL Remission< 2 ng/mL Initial therapy transphenoidal micro surgery. Radiation th/ reserved for patients w/ inadequat responses to surgery & medical therapy
Treatment
Surgical treatment : for small or moderate size tumors (< 2cm) transphenoidal-Surgery is the treatment of choice for microadenomas (90% cure) Medical treatment: Somatostatin analog Octreotide acetate (Sandostatin) & Lanreotide (Somat uline) the therapy of choice with residual GH hypersecr. Following surgery Radiotherapy
HIPOTHALAMUS
GHRH SOMATOSTATIN
PITUITARY
DOPAMINE-AGONIST DRUGS:BROMOCRIP TINE,CABERGOLINE
GH
GH-RECEPTOR
IGF-1
IGF-1 :Insulin like growth factor
GH
Clinical Features
Onset insidious, usual 20-40 y, F:M :8:1, Ectopic ACTH M:F:3:1 Central Obesity, hypertension, glucose intolerance, gonadal disfunction, moon facies, plethora osteopenia, muscle weakness, violaceous striae, hirsutism, acne,poor wound healing, fungal infection,
CRANIOPHARYNGIOMA
Children and adolescence >80% hypothalamic-pituitary deficiencies GH deficiency most common, growth retardation, gonadotropin deficiency Symptom: intracranii pressure, decreased visual acuity Diagnose:MRI
Pituitary Insufficiency
Pituitay Insufficiency
Panhypopituitarism classic manifestation of pituitary adenomas; Hypogonadism c/ GnRH screened FSH/LH to exclude primary gonadal failure TSH or ACTH deficiency is relatively unusual
Posterior Pituitary
Antidiuretic hormon (ADH; Vasopressin)
Diabetes Insipidus : Deficient ADH action Synd Inappropriate ADH : high plasma ADH concentration
DIABETES INSIPIDUS
Is disorder of water balance caused by nonsmotic renal losses of water Etiology : deficient argenine vaasopressin (AVP=ADH) secretion (central) or end organ unresponsivenes to AVP (nephrogenic) AVP is released from cells in the posterior pituitary gland increase water permeability at the distal tubule and collecting duct of the nephron
DIABETES INSIPIDUS
Classification
Central DI; Hypophysectomy, idiopathic, familial, tumor/cyst, granuloma, autoimmune Nephrogenic DI; chronic renal disease, hypokalemia,hypercalcemia, familial, etc
DD: Primary polydipsy (Psychogenic, compulsive water drinking)
DIABETES INSIPIDUS
Symptoms:
Thirst, polyurea, daily urine volume >3 L Hypernatremia weakness,altered mentaal status, coma, seizuresSigns: Physical examination is` usually normal
Laboratory Evaluation:
Spesific gravity <1.010 Urine osmolality <300 m Osm/kg Hypernatremia
Diagnosis
HighPlasma osmolality Urine osmolality reduced Water Deprivation; Spesific-Gravity <1.005 (200mosm/Kg of water) Plasma Vasopressin low in Neurogenic DI and N/high in nephrogenic DI, low in psychogenic polydipsia ADH Radioimmunoassays
Treatment
2 goals: replace the water deficit & treat underlying abnormality Central DI
Desmopressin acetat = AVP analog DDAVP)
Nephrogenic DI
Underlying disorder should be treated if possible, diuretic, prostaglandin synthesis inhibitors, amiloride
Treatment
Fluid restriction Diuretics
Cushings syndrome
Adrenocortical hypofunction
Addisons disease
ADRENAL INCIDENTALOMAS
Masses found incidentally during radiographic imaging of the abdomen Incidence : 0.35-4.36% in general population In Evaluation such mass: Is the mass benign or malignant? Does the mass secrete hormones or mass disfunction
DD ADRENAL INCIDENTALOMA
Benign: Non hormone secreting (lipoma,cyst, ganglioneuroma, adenoma) Hormone secreting (pheochromocytoma, aldosteronism, subclinical Cushings syndrome Malignant Adrenocortical carcinoma metastatic neoplasm lymphoma
ADRENAL INCIDENTALOMAS
Size is important: Adrenal masses >4cm more likely malignant surgical resection should be consideration The great majority (+ 89%) are benign, non functioning masses A full biochemical workup should be completed before surgery is done
CUSHINGS SYNDROME
Chronic glucocorticoid excesssymptoms & Physical features CS Iatrogenic CS ( Chronic glucocorticoid therapy): most commonly Spontaneous CS : Pituitary (Cushing disease) Adrenal ACTH secretion non pituitary tumor (ectopic ACTH Syndrome)
CUSHINGS SYNDROME
Classification
ACTH-dependent
Pituitary adenoma (Cushing disease) 70% Nonpituitary neoplasma (ectopic ACTH)
ACTH-independent
Iatrogenic (glucocorticoid, megestrol acetat) Adrenal neoplasma (adenoma, carcinoma), Hyperplasia Factitious
CUSHINGS SYNDROME
Cushings syndrome suspected Overnight 1 mg DST AM cortisol > 1.8 ug/dl AM cortisol <1.8 ug/dl Normal
Endocrinology consultation
CUSHINGS SYNDROME
Cushings syndrome established
ACTH IRMA
IPS:P>2.0
Adrenal surgery
Ectopic ACTH
Pituitary Surgery
CUSHINGS SYNDROME
Treatment:
CUSHINGdisease Microsurgery, Radiation therapy, Adrenal tumors
Unilateral adrenalectomy
Ectopic ACTH syndrome Benign surgical treatment Malignant : Ketokonazole, metyrapone IATROGENIK (CUSHINGOID)
Tapering of Alternate day regimen
Hirsutism
Post adrenalectomy
Addisons Disease
Etiologi: tbc (prior 1920), Autoimmune adrenalitis adrenal atrophy (80%) Associated other immunologic and autoimmune endocrine disorders, AIDS, malignant disease Rare, female >>, 30-50 year Clinical features: weakness, fatigue, anorexia, weight loss, hyperpegmentasi, hypotension,
Addisons disease
Laboratorium :
Hiponatrimia- hiperkalemia (classic) Radiologis /CT Scan
Diagnosis
Basal adrenokortical steroid Normal Rapid ACTH stimulation test ACTH plasma
Treatment:
Replacement therapy cortisol
ACTH
Angiotensin II Angiotensin I
Primary Hyperaldosteronism
Accounts for about 0.7% of cases of hypertension, Women >>, unilateral adrenocortical adenoma (Conns syndrome, 73%), 27% bilateral Hyperaldosteronism: hypertension, hypokalemia, alkalosis
Primary Hyperaldosteronism
Clinical finding: Hypertension, muscular weakness, paresthesias, headache, polydipsia, polyuria, moderate hypertension (malignant is rare) Laboratory finding: Serum potassium low, 24 hours urine collection aldosterone Imaging: CT-scan
Primary Hyperaldosteronsm
Treatment: Laparoscopic adrenalectomy, Spironolactone, antihypertensive agent Complication: Renal damage Prognosis: Improved by early diagnosis and treatment, only 2% malignant
Pheochromocytoma
Symptoms and Signs Usually lethal unless diagnosed and treated severe headache, perspiration, palpitation, anxiety, tremor, tachycardia Attack cyanosis, facial pallor Classical symptomatic triad: headache, sweating, palpitations Laboratory finding Urinary cathecolamines, metanephrine, creatinine, Urinary VMA
Common Symptoms in Patients with Hypertension Due to Pheochromocytoma. Symptoms during or following paroxysms Headache Sweating Forceful heartbeat with or without tachycardia Anxiety or fear of impending death Tremor Fatigue or exhaustion
Constipation
Pheochromocytoma
Localisation
CT scanning
Overall accuracy 90%-95% for adrenal tumours Less accurate for extra adrenal tumours
Pheochromocytoma
Treatment
Surgery Preoperative preparation To control hypertension & prevent CVS complications. Alpha adrenergic blockade
Phenoxybenzamine 10 mg qds 1-2 weeks before surgery Beta blockade propanolol 10 mg qds 2-3 days
Pheochromocytoma
Treatment Laparoscopic removal of the tumor treatment of choice, open laparatomy Prognosis Depends early diagnosis is made
HARSINEN SANUSI
http://arbl.cvmbs.colostate.edu/hbooks/pathphys/endocrine/thyroid/anatomy.html
ORGANIFICATION
PEROXIDASE H2O2
OXIDIZED IODIDE
Tyr
Tyr
Tyrosine?
STORAGE
Iodinase
AA TGB Tyrosine
DEIODINATION RELEASE
MIT DIT
MIT
DIT
PROTEOLYSIS
TGB
T3 T4
T3 T4
Protease
T3 --TGB
T4 --TGB
CAPILLARY
FOLLICULAR CELL
Cryer PE. Diagnostic endocrinology 1976:35
COLLOID
T3
PORTAL SYSTEM
I
ANTERIOR PITUITARY
T4
+
TSH
FREE
T3 _
T4
TISSUE
T3
I
THYROID
+ T4
Thyroid enlargement which may be diffuse or nodular Symptom of thyroid deficiency or Hypothyroidism Symptoms of thyroid hormon excess, or Hyperthyroidism
Physical Examination
Inspection : Good light coming from behind the examiner, The patient is instructed to swallow a sip of water, Observe the gland as it moves up and down. Enlargement and nodularity can often be noted.
Physical Examination
Palpate the gland from behind the patient with the middle threes fingers on each lobe while the patients swallows. Nodules can be measured in a similar way.
Physical Examination
On physical examination the normal thyroid gland about 2cm in vertical dimension and about 1cm in horizontal dimention above the isthmus Enlarged thyroid gland is called Goiter The generalized enlargement is termed diffuse goiter, irreguler or lumpy enlargement is called nodular goiter
Diffuse goiter
Simple diffus goiter Hypertiroidism Hashimoto thyroiditis
Nodular goiter
1. Thyroid nodul 2. Thyroid cyst
3. Adenomatosa goiter 4. Subacut /chronis thyroiditis 5. Plummer thyroiditis
THYROID DISEASES
HYPERTHYROIDISM HYPOTHYROIDISM THYROIDITIS THYROID NODUL
THYROID DYSFUNCTION
PREVALENCE
Thyrotoxicosis is the clinical syndrome that results when tissues are exposed to high levels of circulating thyroid hormone. Thyroxicosis is due to hyperactivity of the thyroid gland or hyperthyroidism Occasionally, thyrotoxicosis may be due to other causes such us excessive ingestion of the thyroid hormone or excessive thyroid hormon from ectopis site
Infiltratif autoimmune
Exophthalmus, oculopathy congestif: cheimosis, conjunctivitis, periorbital edema Ulcerasi Cornea , neuritis optica, atrophi n opticus
Definition
No signs no symptoms Only signs, no symptoms, (signs limited to upper lid retraction, stare,lid lag) Soft tissue involvement (symptom & signs) Proptosis (measured with Hertel exophthalmometer) Extraocular muscle involvement Corneal involvement Sight loss (optic nerve involvement)
DISEASE SEVERITY
Thyroid eye disease can be divided into
MILD DISEASE
Usually young patient Dry eyes---->lubricants Lid retraction Lid malposition-entropion Mild proptosis
MODERATE DISEASE
LID RETRACTION
HERTEL EXOPHTHALMOMETER
EXOPHTHALMOS : >18 MM
Thyroid Dermopathy
Thickening of the skin,over the lower tibia due to accumulation glycosaminoglicans , rare (2-3%) TSH-R Ab high titer Osteopathy in the metacarpal bones
Suspected hyperthyroidism TSH &FT4 Low TSH & Normal FT4 Measure FT3
TSH- secreting pituitary adenoma. Low TSH & high FT4 Normal / high TSH & high FT4
Normal FT3 Subclinical hyperthyroidism Evolving Graves disease Or toxic nodular goiter Excess thyroxine replacement Non thyroidal illness
High FT3
Hyperthyroidism
T3 Hyperthyroidism
Gravesdisease Toxic nodular goiter Thyroiditis Gestational Hyperthyroidism Factitious or iatrogenic hyperthyroidism Thyroid Carcinoma Struma Ovarii Tumor secreting Chorionic gonadotropin Familial nonautoimmun hyperthyroidism
Older patients: weight loss, small goiter, slow AF, severe depression with none clinical features
Complication
Thyrotoxic crisis(thyroid storm):
Clinical manifestation:Fever,Sweating, flushing, tachycardia/AF, heart failure, agitation,delirium, coma, jaundice, nausea vomiting and diarhea. Treatment: Propranolol 1-2 mg IV, PTU 250 mg every 6 hours. Hydrocortison, supportive therapy
Clinical manifestation marked hypermetabolism, excessive adrenergic response, fever, flushing, sweating, tachicardia, AF, heart failure, delirium , coma, GI Symptoms
HYPOTHYROIDISM
HYPOTHYROIDISM
Etiology
Primary:Hashimoto thyroiditis, Radio
active iodine therapy for Graves disease, Subtotal thyroidectomy, Excesive iodide intake, subacute thyyroiditis, Iodide deficiency
Secondary :
Hypopituitarism due to pituitary adenoma
Tertiary :
Hypothalamic disfunction (rare)
HYPOTIROIDISM
Clinical finding
Incidence : Various causes depending geographic & enviromental factors Hashimoto thyroiditis the most common cause of hyperthyroidism Newborn infants (Cretinism) Fatigue, coldness, weight gain, constipation, menstrual irregularities, muscle cramps
HYPOTIROIDISM
Physical findings: Cool,rough, dry skin, puffy face and hands, ahoarse voice, slow reflexes Cardiovascular sign: bradycardia, diminished CO, low voltage QRS, cardiac enlargement Pulmonary function: Respiratory failure Intestinal paralysis slowed , chronic constipation, ileus Renal function. Decresed GFR, renal impairement Anemia, Severe muscle cramp, parestesias, muscle weaknes CNS symptoms: fatigue, inability to concentrate
Hypothalamus
Somatostatin
TSH
Pituitary
Tissues T3, T4
THYROID
Complication
Myxedema coma end stage of untreated hypothyroidism, Cause Radiotherapy in Graves Disease Myxedema & Heart disease CAD Hypothyroidism Neuropsychiatric disease depression, confuse, paranoid, manic
Treatment Hypothyroidism
Levothyroxine (T4), not liothyronine (T3) because rapid absorption, short half life, transient effect. Dosis T4, 1X in the morning to avoid insomnia 0.05 mg-0.2 mg/d Mixedema coma ICU, intubation & mechanical ventilation, Treat infection, heart failure, IV drips with caution, levothyroxin IV
1 Hypothyroidism
Hyperthyroidism
www.hsc.missouri.edu/~daveg/thyroid/thy_dis.html
Complication
Myxedema coma end stage of untreated hypothyroidism, Cause Radiotherapy in Graves Disease Myxedema & Heart disease CAD Hypothyroidism Neuropsychiatric disease depression, confuse, paranoid, manic
Definition
Thyroiditis heterogenous group of inflamatory disorders the thyroid gland Etiologies range from autoimmune to infectious origins Clinical course Acute, subacute, or chronic. Can be euthyroid, transient phase thyrotoxicosis and / or hypothyroidism. Painless or painfull
Classification of thyroiditis
I. Autoimmune thyroiditis Chronic autoimune thyroiditis
Hashimotos thyroiditis Atrophic thyroiditis Focal thyroiditis Juvenile thyroiditis
Classification of thyroiditis
Hystologic classification
Chronic lymphocytic
Synonims
Chronic lymphocytic thyroiditis, Hashimotos thyroiditis Subacut lymphocytic thyroiditis, Postpartum thyroiditis, Sporadic painless thyroiditis Subacut granulomatous thyroiditis De Quervains thyroiditis Suppurative thyroiditis Acut thyroiditis Riedels struma Riedels thyroiditis
Fibrous thyroiditis
Dr Hakaru Hashimoto
Hashimotos thyroiditis Hashimoto thyroiditis is the most common cause of hypothyroidism & goiter in the United States
Statosky J et al. Am Acad of Family physicians 2000;61:1054
Hashimotos thyroiditis
Etiology & pathogenesis HT is immunologic disorder which lymphocytes become sensitized to thyroidal antigens and auto antibodies are performed. Thyroid antibodies in HT are: 1.Thyroglobulin antibody (Tg Ab) 2. Thyroid peroxidase antibody (TPO Ab) = Microsomal antibody) 3. TSH Receptor blocking antibody (TSHR Ab block)
Laboratory findings
T4 N/ low, TSH will be elevated. RAIU may be high, normal or low Tg Ab & TPO Ab positif Fine needle aspiration biopsy large infiltration lymphocytes Hurttle cells
Diagnostic procedures
Test of thyroid autoimmunity: TPOAb 95% + in Hashimoto thyroiditis & 90% Atrophic thyroiditis TgAb less frequently + Diagnostic specificity of thyroid antibody tests is not absolute. Test for thyroid function TSH, fT4 RAIU: normal, low or high. USG:diffusely reduced echogenecity. FNAB not necessary,excep. rapidly enlarging goiter
Positive
Negative
Hashimotos thyroiditis
US Biopsy
*Simple goiter,
adenomatous goiter etc
Positive
Negative
Other diseases*
Treatment
Goiter small & asymptomatic not require therapy Levo-thyroxine is given over hypothyroidism to supress TSH & decreased serum thyroid antibody. Levo-thyroxine in euthyroid, still controversial
Treatment
Corticosteroids : regression pain, reduction in size of the goiter, thyroid antibody, not recommended in benign disease.
Surgery indicated pain, cosmetic, or pressure symptoms after levothyroxine and corticosteroid therapy.
Riedels thyroiditis
Rare 1,06/100.000, middle age or elderly women Etiology unknown (autoimmune process or primary fibrotic disorder) Characterized fibrosis replaces normal thyroid parenchyma,1/3 cases multifocal fibrosclerosis
Riedels thyroiditis
Thyroid fibrosis (stony hard,woody), painless, progressive anterior neck mass, Generalized fibrosing (1/3 patients), pressure symptoms laryngeal nerve paralysis or hypoparathyroidism (rare) Usually euthyroidism, hypothyroidism (30%) Laboratorium : non spesific USG/CT-Scan inconclusive Difinitive diagnosis open Biopsy
Riedels thyroiditis
Treatment: Corticosteroids medical treatment of choice Tamoxipen, methotrexate inhibitor fibroblast proliferation ( early stages) Levothyroxine hypothyroidism Surgical care diagnosis, relieving tracheal compression Mortality asphyxia (6-10%), extrathyroidal fibrotic lesions may complicate the prognosis
Subacute thyroiditis
Cause unknown ( viral infection (?) preceded URT infection, coincidence viral disease (mumps, measles, Echo virus, adeno virus, epst. Barr virus, influenza) Women : Men (3-5:1) Onset: 20-60 yr Summer
Subacute thyroiditis
Palpation thyroid: enlarged, asymetrical, nodul, firm, tender & painful. Thyrotoxicosis during inflamatory phase euthyroidism hypothyroidism euthyroidism (4th phases) Laboratorium: ESR increase, leukocyt N/ increase, fT4,,TSH, RAIU Recovery 4-6 months, spontaneous
remitting
Changes in serum T4 & Radiactive iodine uptake in patients with subacute Thyroiditis
T4 ug/dL
20
T4
40
15 10
30
20
5
I Eu 4 Hypo 11 Eu -
10
131
0 Phase : Weeks:
0
Woolf PD, Daly R :Am J Med 197;60:73
Hyper 1
Phase
T4 &/T3 Level
TSH level
Low
RAIU value
<5%
Thyrotoxicosis
High
Hypothyroid
Recovery
Low
Normal
Normal,or high
High to normal
Normal to high
High to normal
Thyroidectomy rarely
YES
N0
RAIU
INCREASED DECREASED
PRESENTING SYMPTOMS
HYPERTHYROIDISM
HYPOTHYROIDISM
RAIU
GRAVES DISEASE
Chronic-pyogenic thyroiditis
Etiology : Salmonella typhosa, syphilis, tuberculosis,echinococcus, actinomyces Symptoms: Suppurative, non suppurative Treatment: antibiotic, drainage
Diagnostic approach
Fine Needle Aspiration (FNA)
10-20% risk of suspicious cytology, therefore thyroid surgery 95% of histology will be benign, and surgery unnecessary
Isotop Scann(CT)
rarely used for evaluation 80% of nodules are cold small cold nodules may be missed hot nodules may be malignant
Ultrasonography (USG)
FNAC
Benign
Malignant
Indeterminate
Follicular
Watch?
Surgery
Repeat FNAC
Surgery
Indeterminate
Surgery
Treatment
Thyroidectomi Jodium 131Radioactive Thyroxine supression
FNA POSITIF MALIGNANCY Differenteated Under 2cm, no invasion Lobectomy and isthmusectomy Levothyroxine for life Over 2cm, or multicentric, or invasive Near total thyroidectomy and modified neck dissection Liothyronine, 75-100 mcg/d for 3 mos, discontinue 2 week. Low iodine diet Scan with 2-5 mCi 131 I Negatitive scan Levothyroxine for life No recurence cure Recurrence + - Scan Local removal to prevent obstruction (palliative therapy) X-ray therapy or chemotherapy (or both) plus levothyroxine replacement therapy Undifferenteated
Follicular cancer
Hurthle Medullary